Regeneron Pharmaceuticals, Inc. Portfolio Stock Holdings
According to the SEC 13F filed on August 7, 2026, Regeneron Pharmaceuticals, Inc. disclosed 3 stock positions valued at approximately $177.22M as of quarter-end June 30, 2026. The largest holdings include Intellia Therapeutics, Inc..
- Report Period
- June 30, 2026
- No. of Stocks
- 3
- Portfolio Value
- $177.22M
Holdings by Sector
Regeneron Pharmaceuticals, Inc. Portfolio Holdings in Q2 2026
1 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. | NTLA | Healthcare | 35.35% | 3,702,995 | - | - | $62,654,675 |